腹腔心律失常与lamotrigine的关联:一个观察性队列研究
Sodam Kim1, Landon Welch2, Bertha De Los Santos1
1Department of Pharmacy Systems and Outcomes and Policy, University of Illinois at Chicago, 833 S Wood Street, Chicago, IL, 60612, USA.
Scientific reports
|June 4, 2025
概括
与替代治疗相比,在双相情感障碍 (BPD) 中使用拉莫特里金 (LTG) 显示出与增加心室动脉冲动 (VT) 风险的统计学上显著关联. 这项现实研究分析了患有BPD,部分发作 (PSZ) 和通用性强力-克隆性发作 (GTSZ) 的患者的静脉发作发生率.
科学领域:
- 药物监督 药物监督 药物监督
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 在患有双相情感障碍 (BPD),部分 (PSZ) 和泛性强力-克隆性 (GTSZ) 的患者中,拉姆特里金 (LTG) 与腹腔动心 (VT) 之间的关联尚未得到充分证实,特别是在结构性心脏病 (SHD) 方面.
- 需要真实世界的数据来比较LTG的心血管安全性与这些患者群体的替代治疗方法.
研究的目的:
- 进行现实世界的比较队列观察研究,以评估与常规处方的替代药物相比,与LTG相关的VT发病率风险.
- 分析LTG和VT之间的关联在被诊断患有BPD,PSZ或GTSZ的成年患者中,有或没有SHD.
主要方法:
- 使用大型医疗保健索赔数据库进行的回顾性观察性安全研究.
- 纳入标准包括在6个月的基线期内被诊断患有BPD,PSZ或GTSZ的成年患者,在6个月的基线期内不患上脑上 (SVT) 或静脉.
- 使用Kaplan-Meier估计器计算了一年的累积VT发生率,调整的危险比率 (HR) 将LTG暴露与控制 (CTR) 进行比较.
主要成果:
- 该研究分析了153,852名LTG用户和213,593名BPD的CTR; 10,275名LTG和24,971名PSZ的CTR;以及5,860名LTG和17,506名GTSZ的CTR.
- 一年的VT累积发病率为LTG的0.79%,而BPD中的CTR为0.68% (调整HR:1.326 [1.122-1.568],p<0.01).
- 对于PSZ,VT发生率为0.76%与0.58% (调整HR:1.403 [0.920-2.138],p=0.11);对于GTSZ,它是0.93%与0.40% (调整HR:1.180 [0.607-2.295],p=0.63).
结论:
- 拉莫特里金 (LTG) 在与替代药物相比,在患有双相情感障碍 (BPD) 的成年患者中,与腹腔动心率 (VT) 的风险增加有关.
- 虽然趋势表明,在部分发作 (PSZ) 和泛性强力-克隆性发作 (GTSZ) 中,LTG可能会增加静脉瘤风险,但这些发现在本研究中没有达到统计意义.
- 进一步的研究可能是有必要的,以阐明在不同的神经和精神疾病中与LTG相关的特定心血管风险.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
291
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
291
Dysrhythmias II: Classification of Tachyarrhythmias
141
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
141
Antiepileptic Drugs: Glutamate Antagonists
528
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
528
Antiepileptic Drugs: Sodium Channel Blockers
963
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
963
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.3K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
685
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
685


